Click for best price
Personalizing Cancer Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Personalizing Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalizing Cancer Drugs. This report contains market size and forecasts of Personalizing Cancer Drugs in global, including the following market information:
Global Personalizing Cancer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Personalizing Cancer Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors are increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents.
We surveyed the Personalizing Cancer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalizing Cancer Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Personalizing Cancer Drugs Market Segment Percentages, by Type, 2022 (%)
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
Global Personalizing Cancer Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Personalizing Cancer Drugs Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
Global Personalizing Cancer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Personalizing Cancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Personalizing Cancer Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Personalizing Cancer Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Personalizing Cancer Drugs, market overview.
Chapter 2: Global Personalizing Cancer Drugs market size in revenue.
Chapter 3: Detailed analysis of Personalizing Cancer Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalizing Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Personalizing Cancer Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Personalizing Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalizing Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalizing Cancer Drugs Overall Market Size
2.1 Global Personalizing Cancer Drugs Market Size: 2022 VS 2029
2.2 Global Personalizing Cancer Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalizing Cancer Drugs Players in Global Market
3.2 Top Global Personalizing Cancer Drugs Companies Ranked by Revenue
3.3 Global Personalizing Cancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Personalizing Cancer Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Personalizing Cancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalizing Cancer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Personalizing Cancer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalizing Cancer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Personalizing Cancer Drugs Market Size Markets, 2022 & 2029
4.1.2 Immunotherapy
4.1.3 Targeted Therapy
4.1.4 Chemotherapy
4.1.5 Hormone Therapy
4.1.6 Others
4.2 By Type - Global Personalizing Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Personalizing Cancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Personalizing Cancer Drugs Revenue, 2024-2029
4.2.3 By Type - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalizing Cancer Drugs Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Blood Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Skin Cancer
5.1.7 Lung Cancer
5.1.8 Others
5.2 By Application - Global Personalizing Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Personalizing Cancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Personalizing Cancer Drugs Revenue, 2024-2029
5.2.3 By Application - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Personalizing Cancer Drugs Market Size, 2022 & 2029
6.2 By Region - Global Personalizing Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Personalizing Cancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Personalizing Cancer Drugs Revenue, 2024-2029
6.2.3 By Region - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Personalizing Cancer Drugs Revenue, 2018-2029
6.3.2 US Personalizing Cancer Drugs Market Size, 2018-2029
6.3.3 Canada Personalizing Cancer Drugs Market Size, 2018-2029
6.3.4 Mexico Personalizing Cancer Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Personalizing Cancer Drugs Revenue, 2018-2029
6.4.2 Germany Personalizing Cancer Drugs Market Size, 2018-2029
6.4.3 France Personalizing Cancer Drugs Market Size, 2018-2029
6.4.4 U.K. Personalizing Cancer Drugs Market Size, 2018-2029
6.4.5 Italy Personalizing Cancer Drugs Market Size, 2018-2029
6.4.6 Russia Personalizing Cancer Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Personalizing Cancer Drugs Market Size, 2018-2029
6.4.8 Benelux Personalizing Cancer Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Personalizing Cancer Drugs Revenue, 2018-2029
6.5.2 China Personalizing Cancer Drugs Market Size, 2018-2029
6.5.3 Japan Personalizing Cancer Drugs Market Size, 2018-2029
6.5.4 South Korea Personalizing Cancer Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Personalizing Cancer Drugs Market Size, 2018-2029
6.5.6 India Personalizing Cancer Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Personalizing Cancer Drugs Revenue, 2018-2029
6.6.2 Brazil Personalizing Cancer Drugs Market Size, 2018-2029
6.6.3 Argentina Personalizing Cancer Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalizing Cancer Drugs Revenue, 2018-2029
6.7.2 Turkey Personalizing Cancer Drugs Market Size, 2018-2029
6.7.3 Israel Personalizing Cancer Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Personalizing Cancer Drugs Market Size, 2018-2029
6.7.5 UAE Personalizing Cancer Drugs Market Size, 2018-2029
7 Personalizing Cancer Drugs Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Personalizing Cancer Drugs Major Product Offerings
7.1.4 Bayer Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Personalizing Cancer Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Personalizing Cancer Drugs Major Product Offerings
7.3.4 Novartis Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Personalizing Cancer Drugs Major Product Offerings
7.4.4 Sanofi Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Personalizing Cancer Drugs Major Product Offerings
7.5.4 Pfizer Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Personalizing Cancer Drugs Major Product Offerings
7.6.4 Amgen Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Personalizing Cancer Drugs Major Product Offerings
7.7.4 Merck Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Personalizing Cancer Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Celgene Corporation
7.9.1 Celgene Corporation Company Summary
7.9.2 Celgene Corporation Business Overview
7.9.3 Celgene Corporation Personalizing Cancer Drugs Major Product Offerings
7.9.4 Celgene Corporation Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.9.5 Celgene Corporation Key News & Latest Developments
7.10 Ariad Pharmaceuticals
7.10.1 Ariad Pharmaceuticals Company Summary
7.10.2 Ariad Pharmaceuticals Business Overview
7.10.3 Ariad Pharmaceuticals Personalizing Cancer Drugs Major Product Offerings
7.10.4 Ariad Pharmaceuticals Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.10.5 Ariad Pharmaceuticals Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Personalizing Cancer Drugs Major Product Offerings
7.11.4 Eli Lilly Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
7.12 Hoffmann-La Roche
7.12.1 Hoffmann-La Roche Company Summary
7.12.2 Hoffmann-La Roche Business Overview
7.12.3 Hoffmann-La Roche Personalizing Cancer Drugs Major Product Offerings
7.12.4 Hoffmann-La Roche Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.12.5 Hoffmann-La Roche Key News & Latest Developments
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Summary
7.13.2 Boehringer Ingelheim Business Overview
7.13.3 Boehringer Ingelheim Personalizing Cancer Drugs Major Product Offerings
7.13.4 Boehringer Ingelheim Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.13.5 Boehringer Ingelheim Key News & Latest Developments
7.14 Johnson and Johnson
7.14.1 Johnson and Johnson Company Summary
7.14.2 Johnson and Johnson Business Overview
7.14.3 Johnson and Johnson Personalizing Cancer Drugs Major Product Offerings
7.14.4 Johnson and Johnson Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.14.5 Johnson and Johnson Key News & Latest Developments
7.15 Teva Pharmaceuticals
7.15.1 Teva Pharmaceuticals Company Summary
7.15.2 Teva Pharmaceuticals Business Overview
7.15.3 Teva Pharmaceuticals Personalizing Cancer Drugs Major Product Offerings
7.15.4 Teva Pharmaceuticals Personalizing Cancer Drugs Revenue in Global Market (2018-2023)
7.15.5 Teva Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Personalizing Cancer Drugs Market Opportunities & Trends in Global Market
Table 2. Personalizing Cancer Drugs Market Drivers in Global Market
Table 3. Personalizing Cancer Drugs Market Restraints in Global Market
Table 4. Key Players of Personalizing Cancer Drugs in Global Market
Table 5. Top Personalizing Cancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Personalizing Cancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Personalizing Cancer Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Personalizing Cancer Drugs Product Type
Table 9. List of Global Tier 1 Personalizing Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Personalizing Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Personalizing Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Personalizing Cancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Personalizing Cancer Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Personalizing Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Personalizing Cancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Personalizing Cancer Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Personalizing Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Personalizing Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Personalizing Cancer Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Personalizing Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Personalizing Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Personalizing Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Personalizing Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Personalizing Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Personalizing Cancer Drugs Product Offerings
Table 32. Bayer Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Personalizing Cancer Drugs Product Offerings
Table 36. GlaxoSmithKline Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Personalizing Cancer Drugs Product Offerings
Table 40. Novartis Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Personalizing Cancer Drugs Product Offerings
Table 44. Sanofi Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Personalizing Cancer Drugs Product Offerings
Table 48. Pfizer Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Personalizing Cancer Drugs Product Offerings
Table 52. Amgen Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Personalizing Cancer Drugs Product Offerings
Table 56. Merck Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Personalizing Cancer Drugs Product Offerings
Table 60. Bristol-Myers Squibb Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Celgene Corporation Company Summary
Table 63. Celgene Corporation Personalizing Cancer Drugs Product Offerings
Table 64. Celgene Corporation Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Celgene Corporation Key News & Latest Developments
Table 66. Ariad Pharmaceuticals Company Summary
Table 67. Ariad Pharmaceuticals Personalizing Cancer Drugs Product Offerings
Table 68. Ariad Pharmaceuticals Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Ariad Pharmaceuticals Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Personalizing Cancer Drugs Product Offerings
Table 72. Eli Lilly Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Hoffmann-La Roche Company Summary
Table 75. Hoffmann-La Roche Personalizing Cancer Drugs Product Offerings
Table 76. Hoffmann-La Roche Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Hoffmann-La Roche Key News & Latest Developments
Table 78. Boehringer Ingelheim Company Summary
Table 79. Boehringer Ingelheim Personalizing Cancer Drugs Product Offerings
Table 80. Boehringer Ingelheim Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Boehringer Ingelheim Key News & Latest Developments
Table 82. Johnson and Johnson Company Summary
Table 83. Johnson and Johnson Personalizing Cancer Drugs Product Offerings
Table 84. Johnson and Johnson Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Johnson and Johnson Key News & Latest Developments
Table 86. Teva Pharmaceuticals Company Summary
Table 87. Teva Pharmaceuticals Personalizing Cancer Drugs Product Offerings
Table 88. Teva Pharmaceuticals Personalizing Cancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Teva Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Personalizing Cancer Drugs Segment by Type in 2022
Figure 2. Personalizing Cancer Drugs Segment by Application in 2022
Figure 3. Global Personalizing Cancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Personalizing Cancer Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Personalizing Cancer Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Personalizing Cancer Drugs Revenue in 2022
Figure 8. By Type - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Personalizing Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Personalizing Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 16. US Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 28. China Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Personalizing Cancer Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Personalizing Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Celgene Corporation Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ariad Pharmaceuticals Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Hoffmann-La Roche Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Boehringer Ingelheim Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Johnson and Johnson Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Teva Pharmaceuticals Personalizing Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
